Stock SYNT SYNTHOMER PLC
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Synthomer plc

Equities

SYNT

GB00BNTVWJ75

Real-time Estimate Cboe Europe
Other stock markets
 05:20:26 2024-04-29 am EDT 		5-day change 1st Jan Change
238 GBX +1.06% Intraday chart for Synthomer plc -2.56% +25.08%
Apr. 17 EARNINGS AND TRADING: Chill Brands shareholder seeks board ejections AN
Apr. 15 Synthomer sells latex compounding operations for EUR27.5 million AN

Summary

  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.43 for the 2023 fiscal year.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • For several months, analysts have been revising their EPS estimates roughly upwards.

Weaknesses

  • According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • Low profitability weakens the company.
  • The group shows a rather high level of debt in proportion to its EBITDA.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • Over the past four months, analysts' average price target has been revised downwards significantly.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Specialty Chemicals

1st Jan change Capi. Investor Rating ESG Refinitiv
SYNTHOMER PLC Stock Synthomer plc
+25.08% 480M
B
ECOLAB INC. Stock Ecolab Inc.
+11.47% 63.22B
A-
SIKA AG Stock Sika AG
-2.27% 46.34B
A-
GIVAUDAN SA Stock Givaudan SA
+14.32% 39.97B
B+
FUJIFILM HOLDINGS CORPORATION Stock Fujifilm Holdings Corporation
+17.83% 25.46B
A-
EMS-CHEMIE HOLDING AG Stock EMS-CHEMIE HOLDING AG
+7.71% 18.68B
C+
CELANESE CORPORATION Stock Celanese Corporation
-0.57% 17.24B
B+
POSCO FUTURE M CO., LTD. Stock Posco Future M Co., Ltd.
-21.73% 15.81B
A-
SYMRISE AG Stock Symrise AG
+1.77% 14.9B
B+
ALBEMARLE CORPORATION Stock Albemarle Corporation
-19.10% 13.74B
C+
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. SYNT Stock
  4. Ratings Synthomer plc